- Home
- EBC vs FOLD Comparison
EBC vs FOLD Comparison
Compare EBC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBC
- FOLD
- Stock Information
- Founded
- EBC 1818
- FOLD 2002
- Country
- EBC United States
- FOLD United States
- Employees
- EBC N/A
- FOLD N/A
- Industry
- EBC Accident &Health Insurance
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- EBC Finance
- FOLD Health Care
- Exchange
- EBC Nasdaq
- FOLD Nasdaq
- Market Cap
- EBC 3.5B
- FOLD 2.9B
- IPO Year
- EBC 2020
- FOLD 2007
- Fundamental
- Price
- EBC $15.30
- FOLD $6.08
- Analyst Decision
- EBC Buy
- FOLD Buy
- Analyst Count
- EBC 2
- FOLD 10
- Target Price
- EBC $19.25
- FOLD $16.22
- AVG Volume (30 Days)
- EBC 1.5M
- FOLD 4.6M
- Earning Date
- EBC 04-24-2025
- FOLD 05-01-2025
- Dividend Yield
- EBC 3.12%
- FOLD N/A
- EPS Growth
- EBC N/A
- FOLD N/A
- EPS
- EBC N/A
- FOLD N/A
- Revenue
- EBC $460,334,000.00
- FOLD $543,141,000.00
- Revenue This Year
- EBC $26.65
- FOLD $21.87
- Revenue Next Year
- EBC $7.02
- FOLD $22.19
- P/E Ratio
- EBC N/A
- FOLD N/A
- Revenue Growth
- EBC N/A
- FOLD 28.25
- 52 Week Low
- EBC $12.22
- FOLD $6.20
- 52 Week High
- EBC $19.40
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- EBC 50.44
- FOLD 29.58
- Support Level
- EBC $14.97
- FOLD $6.63
- Resistance Level
- EBC $15.54
- FOLD $7.71
- Average True Range (ATR)
- EBC 0.40
- FOLD 0.30
- MACD
- EBC 0.10
- FOLD -0.05
- Stochastic Oscillator
- EBC 58.96
- FOLD 13.76
About EBC Eastern Bankshares Inc.
Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment; Banking business which offers a range of banking lending, savings, and small business offerings, and its wealth management and trust operations.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.